Annotations: 5LC2

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2 Family	FAM3B/PANDER-like	8055724	4007431	SCOP2 (2022-06-29)
A	SCOP2 Superfamily	FAM3B/PANDER-like	8055728	3002300	SCOP2 (2022-06-29)
B	SCOP2B Superfamily	FAM3B/PANDER-like	8055728	3002300	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	ILEI	e5lc2A1	A: a+b two layers	X: FAM3 superfamily (From Topology)	H: FAM3 superfamily (From Topology)	T: FAM3 superfamily	F: ILEI	ECOD (1.6)
B	ILEI	e5lc2B1	A: a+b two layers	X: FAM3 superfamily (From Topology)	H: FAM3 superfamily (From Topology)	T: FAM3 superfamily	F: ILEI	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B	PF15711	Interleukin-like EMT inducer (ILEI)	Interleukin-like EMT inducer	ILEI is a family of proteins found in vertebrates. It is heavily involved in the process of the transition from epithelial to mesenchymal tissue - EMT - during all of embryonic development, cancer progression, metastasis, and chronic inflammation/fib ...	ILEI is a family of proteins found in vertebrates. It is heavily involved in the process of the transition from epithelial to mesenchymal tissue - EMT - during all of embryonic development, cancer progression, metastasis, and chronic inflammation/fibrosis. ILEI is upregulated exclusively at the level of translation, and abnormal ILEI expression, ie cytoplasmic over-expression instead of vesicular localisation, is associated with EMT in human cancerous tissue [1]. In order to induce and maintain the EMT of hepatocytes in a TGF-beta-independent fashion ILEI needs the cooperation of oncogenic Ras [2].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B	Protein FAM3C	binding carbohydrate binding protein binding molecular function activator activity signaling receptor binding molecular function regulator activity cytokine activity signaling receptor regulator activity receptor ligand activity signaling receptor activator activity	-	membrane-bounded organelle vesicle lumen intracellular anatomical structure intracellular vesicle membrane-enclosed lumen cytoplasmic vesicle lumen cellular anatomical entity intracellular membrane-bounded organelle secretory granule lumen endomembrane system intracellular organelle lumen intracellular organelle platelet dense granule lumen cytoplasmic vesicle membrane-bounded organelle vesicle lumen intracellular anatomical structure intracellular vesicle membrane-enclosed lumen cytoplasmic vesicle lumen cellular anatomical entity intracellular membrane-bounded organelle secretory granule lumen endomembrane system intracellular organelle lumen intracellular organelle platelet dense granule lumen cytoplasmic vesicle organelle lumen platelet dense granule organelle secretory granule secretory vesicle cytoplasm vesicle Golgi apparatus extracellular region extracellular space extracellular exosome extracellular vesicle extracellular organelle extracellular membrane-bounded organelle

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B	IPR039475	FAM3C (ILEI) domain	Domain
A, B	IPR039477	ILEI/PANDER domain	Domain
A, B	IPR039220	FAM3 family	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B	Pharos: Q92520	amyotrophic lateral sclerosis cancer Emery-Dreifuss muscular dystrophy large cell medulloblastoma osteosarcoma pituitary cancer B-cell chronic lymphocytic leukemia Crohn disease hereditary spastic paraplegia lymphoplasmacytic lymphoma ovarian cancer plasma cell myeloma bone disease Duchenne muscular dystrophy juvenile dermatomyositis amyotrophic lateral sclerosis cancer Emery-Dreifuss muscular dystrophy large cell medulloblastoma osteosarcoma pituitary cancer B-cell chronic lymphocytic leukemia Crohn disease hereditary spastic paraplegia lymphoplasmacytic lymphoma ovarian cancer plasma cell myeloma bone disease Duchenne muscular dystrophy juvenile dermatomyositis osteoporosis Pick disease ulcerative colitis

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.